GE Healthcare unveils €30.5 million manufacturing line in Cork

GE Healthcare has opened a new manufacturing line at the company’s site in Carrigtohill, Co. Cork.

The $30 million (€30.5 million) project was completed over the course of two years.

The new line, which will create 140 jobs at the site, is expected to produce injectable diagnostic imaging agents used in X-ray and CT procedures worldwide.

Current vacancies include engineers and project managers as well as operators and facility management.

“We expect global demand for iodinated contrast agents to double over the next decade due to the growth in CT imaging,” said Kevin O’Neill, president and chief executive of GE Healthcare Pharmaceutical Diagnostics.

“As an industry leader, we recognize our responsibility to meet this growing demand from customers and patients, and this new production line is part of our broader commitment to produce an additional 30 million doses of contrast media for patients annually by 2025.”

The pharmaceutical diagnostics business currently manufactures imaging products to support over 100 million procedures per year, with the Cork facility expected to increase production by over 50 per cent by 2025.

GE Healthcare’s pharmaceutical diagnostics business employs over 4,000 people at seven manufacturing sites worldwide. The Cork plant opened in 1993 and currently employs 765 people. GE Healthcare unveils €30.5 million manufacturing line in Cork

Fry Electronics Team

Fry is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button